These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33768656)

  • 1. Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study.
    Rinaldi M; Bartoletti M; Ferrarese A; Franceschini E; Campoli C; Coladonato S; Pascale R; Tedeschi S; Gatti M; Cricca M; Ambretti S; Siniscalchi A; Morelli MC; Cescon M; Cillo U; Di Benedetto F; Burra P; Mussini C; Cristini F; Lewis R; Viale P; Giannella M
    Transpl Infect Dis; 2021 Aug; 23(4):e13608. PubMed ID: 33768656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
    Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M
    Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified regimen of targeted antifungal prophylaxis in liver transplant recipients: A single-center experience.
    Lavezzo B; Patrono D; Tandoi F; Martini S; Fop F; Ballerini V; Stratta C; Skurzak S; Lupo F; Strignano P; Donadio PP; Salizzoni M; Romagnoli R; De Rosa FG
    Transpl Infect Dis; 2018 Apr; 20(2):e12859. PubMed ID: 29427394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
    Cornely OA; Hoenigl M; Lass-Flörl C; Chen SC; Kontoyiannis DP; Morrissey CO; Thompson GR;
    Mycoses; 2019 Sep; 62(9):716-729. PubMed ID: 31254420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients.
    Yetmar ZA; Lahr B; Brumble L; Gea Banacloche J; Steidley DE; Kushwaha S; Beam E
    Transpl Infect Dis; 2021 Oct; 23(5):e13714. PubMed ID: 34435415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study.
    Pappas PG; Andes D; Schuster M; Hadley S; Rabkin J; Merion RM; Kauffman CA; Huckabee C; Cloud GA; Dismukes WE; Karchmer AW
    Am J Transplant; 2006 Feb; 6(2):386-91. PubMed ID: 16426325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
    Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
    Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted fungal prophylaxis protocol with static dosed fluconazole significantly reduces invasive fungal infection after liver transplantation.
    Jorgenson MR; Descourouez JL; Marka NA; Leverson GE; Smith JA; Andes DR; Fernandez LA; Foley DP
    Transpl Infect Dis; 2019 Oct; 21(5):e13156. PubMed ID: 31390109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
    Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W
    Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of targeted versus universal prophylaxis for the prevention of invasive fungal infections following lung transplantation.
    Linder KA; Kauffman CA; Patel TS; Fitzgerald LJ; Richards BJ; Miceli MH
    Transpl Infect Dis; 2021 Feb; 23(1):e13448. PubMed ID: 33448560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
    Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
    Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?
    Utsumi M; Umeda Y; Yagi T; Nagasaka T; Shinoura S; Yoshida R; Nobuoka D; Kuise T; Fuji T; Takagi K; Takaki A; Fujiwara T
    Dig Surg; 2019; 36(1):59-66. PubMed ID: 29649828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
    Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
    Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Fungal Infection After Lung Transplantation: Epidemiology in the Setting of Antifungal Prophylaxis.
    Baker AW; Maziarz EK; Arnold CJ; Johnson MD; Workman AD; Reynolds JM; Perfect JR; Alexander BD
    Clin Infect Dis; 2020 Jan; 70(1):30-39. PubMed ID: 30801642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection.
    Pepeler MS; Yildiz Ş; Yegin ZA; Özkurt ZN; Tunçcan ÖG; Erbaş G; Köktürk N; Kalkanci A; Yildirim Z
    J Infect Dev Ctries; 2018 Sep; 12(9):799-805. PubMed ID: 31999640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once weekly fluconazole for antifungal prophylaxis post-liver transplantation.
    Trudeau RE; Bowman LJ; Wills AR; Crippin JS; Chapman WC; Anderson C
    HPB (Oxford); 2013 Jul; 15(7):541-7. PubMed ID: 23458063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.